Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria-CURE Results.
Kolkhir P, Laires PA, Salameh P, Asero R, Bizjak M, Košnik M, Dissemond J, van Doorn M, Hawro T, Kasperska-Zajac A, Zajac M, Kocatürk E, Peter J, Parisi CAS, Ritchie CA, Kulthanan K, Tuchinda P, Fomina D, Kovalkova E, Khoshkhui M, Kouzegaran S, Papapostolou N, Du-Thanh A, Kamegashira A, Meshkova R, Vitchuk A, Bauer A, Grattan C, Staubach P, Bouillet L, Giménez-Arnau AM, Maurer M, Weller K. Kolkhir P, et al. J Allergy Clin Immunol Pract. 2023 Feb;11(2):610-620.e5. doi: 10.1016/j.jaip.2022.11.016. Epub 2022 Dec 5. J Allergy Clin Immunol Pract. 2023. PMID: 36481420
Home-Use Hyaluronic Acid Jet Injectors: Unreliable and Unsafe.
Juch RNS, Bik L, Boeijink N, de Vos J, Dobbe IJGG, Bloemen PR, van Doorn MBA, Velthuis P, Aalders MCG, Wolkerstorfer A. Juch RNS, et al. Among authors: van doorn mba. Dermatol Surg. 2024 Jan 1;50(1):62-68. doi: 10.1097/DSS.0000000000003971. Epub 2023 Oct 5. Dermatol Surg. 2024. PMID: 37815475
Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.
Rousel J, Saghari M, Pagan L, Nădăban A, Gambrah T, Theelen B, de Kam ML, Haakman J, van der Wall HEC, Feiss GL, Niemeyer-van der Kolk T, Burggraaf J, Bouwstra JA, Rissmann R, van Doorn MBA. Rousel J, et al. Among authors: van doorn mba. Int J Mol Sci. 2023 Sep 20;24(18):14315. doi: 10.3390/ijms241814315. Int J Mol Sci. 2023. PMID: 37762625 Free PMC article. Clinical Trial.
Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.
Busard CI, Menting SP, van Bezooijen JS, van den Reek JM, Hutten BA, Prens EP, de Jong EM, van Doorn MB, Spuls PI. Busard CI, et al. Among authors: van den reek jm, van doorn mb, van bezooijen js. Trials. 2017 Feb 2;18(1):52. doi: 10.1186/s13063-017-1777-y. Trials. 2017. PMID: 28148280 Free PMC article. Clinical Trial.
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study.
van den Reek JMPA, van Vugt LJ, van Doorn MBA, van der Kraaij GE, de Kort WJA, Lucker GPH, Horvath B, Njoo MD, Bovenschen HJ, Ossenkoppele PM, De Bruin-Weller MS, de Groot M, Mommers R, Prevoo RLMA, van de Kerkhof PCM, Spuls PI, Kievit W, de Jong EMGJ. van den Reek JMPA, et al. Acta Derm Venereol. 2018 Jul 11;98(7):648-654. doi: 10.2340/00015555-2900. Acta Derm Venereol. 2018. PMID: 29405245 Free article.
118 results